.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
Disclaimer:
The content provided on this website and in our research reports is for informational purposes only and does not constitute financial advice, an offer to sell, or a solicitation of an offer to buy any securities.
All investments involve risk, including the loss of principal. Past performance is not indicative of future results. The information presented is based on data believed to be reliable, but we do not guarantee its accuracy or completeness.
The "Institutional Grade" designation refers to the depth of methodology (DCF, sensitivity analysis, clinical trial review) utilized in our reports, which mirrors the processes used by institutional firms. It does not imply a specific regulatory classification in all jurisdictions.
.png)
.png)
.png)
.png)
Professional investors rely on qualified equity research to inform their decisions. We provide the same research for individual investors.
ABOUT INVESTMENT REPORTS
In finance, investment reports are the core of many investment decisions for professional investors.
IMPACT OF INVESTMENT REPORT ON PERFORMANCE
Performance Overtime
Fundamentals
Valuation
Scenarios
Assess the company's strengths and risks.
Provide an accurate asset valuation, helping spot market opportunities.
Detail scenarios for varied market conditions to navigate uncertainty.
Download our sample research report
Investment reports are
priced for institutions.
Mean annual price +120'000$
How are we able to make our research accessible to everyone at a fair price ?
The Institutional Burden
Large banks are required to cover entire markets.
Our Focused Approach
We focus exclusively on sectors where we have deep expertise.
ABOUT ELAM1
ELAM1 is a Switzerland-registered equity research firm specializing in healthcare and biotechnology. With more than 15 years of experience, we assist financial professionals to invest in the healthcare and biotechnology sectors.
15+
Global
$500M+
Years Of Experience In Finance
Clients: USA, UAE, Switzerland, France
Assets Under Advisement
Our trusted partners
Our proprietary research has been resilient to various market conditions.
Investment research made accessible
Receive our institutional grade research.
Contact Us
For inquiries regarding our research or subscription services.
Cancel Anytime, Free of Charges
.png)
.png)
.png)
.png)
.png)
Impact of investment reports on performance
An investment report is a structured analysis of an asset to take informed decisions.
Investment research
for individual investors.
Professional investors rely on qualified equity research to inform their decisions. We provide the same research for individual investors.
WHAT ARE INVESTMENT REPORTS ?
In finance, investment reports are the core of many investment decisions for professional investors.
Performance Overtime
.png)
Fundamentals
Assess the company’s strengths and risks.
Valuation
Offer an accurate asset valuation, helping spot market opportunities.
Scenarios
Detail scenarios for varied market conditions to navigate uncertainty.
Download our sample research report
Investment reports are priced for institutions
Mean annual price +120'000$
.png)
How are we able to make our research accessible to everyone at a fair price ?
The Institutional Burden
Large banks are required to cover entire markets.
We focus exclusively on sectors where we have deep expertise.
Our Focused Approach
ABOUT ELAM1
ELAM1 is a Switzerland-registered equity research firm specializing in healthcare and biotechnology. With more than 15 years of experience, we assist financial professionals to invest in the healthcare and biotechnology sectors.
.png)
15+
Years Of Experience in Finance
Global
Clients: USA, UAE, Switzerland, France
$500M+
Assets Under Advisement
Our proprietary research
has been resilient to various market conditions.
.png)
AVERAGE RETURN
35.4%
Per Recommandation
570%
TOTAL RETURN
Since Inception
Companies Analyzed
COVERAGE
45+
Readers Each Months
MONTHLY READERS
3'000+
Our Trusted Partners
.png)
Investment research made accessible
.png)
Receive our institutional grade research.
Our reports are composed of :
1. Executive Report
Understand the stock at a glance with key metrics and thesis summaries.
2. In-Depth Analysis
Comprehensive detailing of our research process over the covered stock.
Follow-up on previous recommendations to manage your position.
3. Active Updates
.png)
Contact Us
For inquiries regarding our research or subscription services
Disclaimer:
The content provided on this website and in our research reports is for informational purposes only and does not constitute financial advice, an offer to sell, or a solicitation of an offer to buy any securities.
All investments involve risk, including the loss of principal. Past performance is not indicative of future results. The information presented is based on data believed to be reliable, but we do not guarantee its accuracy or completeness.
The "Institutional Grade" designation refers to the depth of methodology (DCF, sensitivity analysis, clinical trial review) utilized in our reports, which are the processes used by common institutional firms. It does not imply a specific regulatory classification in all jurisdictions.
ABOUT ELAM1
Cancel anytime, free of charges.